Ketek
In May 2006, the U.S. Food and Drug Administration (FDA) recommended that a black box warning be added to the Ketek (telithromycin) label, stating that severe, life-threatening, and in some cases fatal episodes of liver toxicity has been reported in patients taking this antibiotic medication. The FDA found that the Ketek usage has been linked to 12 cases of liver failure, including four deaths and drug-induced hepatitis. In some cases, liver transplant is the only option available to the patient.
Ketek is an antibiotic used to treat respiratory infections. On February 12, 2007, the FDA announced a revision to the labeling of Ketek to improve patient safety. The agency restricted usage of the drug to treatment of community-acquired pneumonia of mild to moderate severity. Prior to this change, Ketek had been prescribed for acute bacterial sinusitis and acute bacterial exacerbation of chronic bronchitis as well. The updated label includes a boxed warning and a contraindication stating that no one with myasthenia gravis should take Ketek. In addition, warnings were strengthened for hepatotoxicity (liver injury), loss of consciousness, and visual disturbances.
If you or a loved one has suffered from any adverse liver events while taking Ketek, The Law Offices of Larry H. Parker can help. We are a talented law firm with the ability and desire to handle your pharmaceutical litigation case successfully. Larry's team of attorneys has recovered 1 billion dollars for our clients. To schedule an absolutely free, confidential, no obligation consultation, submit our case form or call us now at (800) 333-0000. At Larry H. Parker, our clients have no upfront costs, charges or fees. The Law Offices of Larry H. Parker takes product liability cases throughout the United States, with offices in Long Beach, Los Angeles, Riverside, and Fresno, California and Phoenix and Tucson, Arizona. Tough times call for tough lawyers. At Larry H. Parker, we'll fight for you!
Ketek® is a registered trademark of Aventis Pharma S.A.
